Legacy App users can now access the Health Portal – just reset your password using email as username.

When to Consider Starting Metformin – with Alex Lazo-Vasquez, MD

When to Consider Starting Metformin – with Alex Lazo-Vasquez, MD

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
Metabolic context is established by discussing insulin resistance and early risk markers. The conversation frames when intervention may be beneficial. Clinical criteria for considering metformin are examined, including lab values and patient profiles. Benefits and limitations are discussed clearly. Practical considerations close the interview, focusing on monitoring, side effects, and long-term use decisions. Individualization remains the key theme.
09:45
29:44

Video Summary

The interview explores when metformin may be considered as part of metabolic health management. Insulin resistance, glucose control, and early risk indicators are discussed. The physician explains why timing and patient selection matter. Metformin is framed as a tool, not a default solution.

Clinical criteria for starting metformin are examined in detail. Lab markers, patient history, and lifestyle factors are emphasized. The discussion highlights benefits such as improved insulin sensitivity. Limitations and contraindications are also addressed.

Practical considerations conclude the interview. Monitoring strategies, side effects, and long-term planning are discussed. Individualized decision making is reinforced as the safest approach. Education supports informed patient choices.

Drug Callouts

Drug
Description
Metformin
Metformin is a medication used to improve insulin sensitivity and glucose regulation. The interview explains when its use may be appropriate.

Condition Callouts

Condition
Description
Insulin resistance
Insulin resistance involves reduced cellular response to insulin. It often precedes metabolic disease.
Prediabetes
Prediabetes refers to impaired glucose regulation that increases diabetes risk.

Key Takeaways

  • Metformin is not a default therapy.
  • Timing and patient selection matter.
  • Lab markers guide treatment decisions.
  • Monitoring and education improve outcomes.
  • Individualized care is essential.